Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 26S proteasome beta5-subunit (PSMB5) is a catalytic component of the 20S core particle within the 26S proteasome. It possesses chymotrypsin-like peptidase activity and is crucial for ATP-dependent degradation of ubiquitinated proteins, regulating protein homeostasis by removing misfolded, damaged, or unnecessary proteins. PSMB5 is a clinically validated target in cancer therapy.
Inhibition of chymotrypsin-like activity of the proteasome
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 26S Proteasome Beta5-Subunit (PSMB5).